BWAY Live signals | Maximize Profits with Getagraph.com

SELL 103266 min ago

@ $6.41

Issued: 13 Feb 2024 @ 14:44

Return: -21.49%

Previous signal: Feb 13 - 12:47

Previous signal: Buy

Return: 0.03 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally...

Stats
Today's Volume	26 208.00
Average Volume	106 311
Market Cap	83.68M
EPS	$0 ( 2024-03-06 )
Next earnings date	( $-0.0200 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.93
ATR14	$0.0320 (0.64%)

Volume Correlation

Long: -0.16 (neutral)

Short: 0.09 (neutral)

Signal:(50.269) Neutral

Brainsway Ltd. Correlation

10 Most Positive Correlations
BFC	0.907
PLAB	0.894
CNTX	0.893
AMTX	0.892
RRBI	0.89
CBAT	0.889
KLIC	0.885
GETVV	0.88
PSCT	0.875
GOGO	0.866

10 Most Negative Correlations
IRTC	-0.897
PWUP	-0.86
AAPL	-0.846
VOXX	-0.845
SWBI	-0.836
PTCT	-0.835
BNIXU	-0.832
RMRM	-0.832
CPRT	-0.829
PODD	-0.822

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Brainsway Ltd. Correlation - Currency/Commodity

-0.12
( neutral )

-0.57
( weak negative )

0.00
( neutral )

-0.66
( moderate negative )

0.08
( neutral )

0.29
( neutral )

Brainsway Ltd. Financials

Annual	2023
Revenue:	$31.79M
Gross Profit:	$23.09M (72.65 %)
EPS:	$-0.250

Q4	2023
Revenue:	$9.03M
Gross Profit:	$6.74M (74.64 %)
EPS:	$0.00760

Q3	2023
Revenue:	$8.30M
Gross Profit:	$6.17M (74.33 %)
EPS:	$-0.0142

Q2	2023
Revenue:	$7.83M
Gross Profit:	$5.73M (73.24 %)
EPS:	$-0.100

Financial Reports:

No articles found.

Brainsway Ltd.

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.